MARKET

GBS

GBS

GBS Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.470
-0.080
-5.16%
After Hours: 1.470 0 0.00% 19:08 01/21 EST
OPEN
1.530
PREV CLOSE
1.550
HIGH
1.530
LOW
1.450
VOLUME
140.13K
TURNOVER
--
52 WEEK HIGH
9.63
52 WEEK LOW
1.260
MARKET CAP
21.88M
P/E (TTM)
-2.2109
1D
5D
1M
3M
1Y
5Y
GBS: Spit it Out: Testing Without the Blood
By John Vandermosten, CFA NASDAQ:GBS READ THE FULL GBS RESEARCH REPORT
Benzinga · 01/08 08:11
Genprex, Creative Medical Technology leads healthcare gainers; Applied Therapeutics, Nutriband among major losers
Gainers: Genprex (NASDAQ:GNPX) +68%, Creative Medical Technology (NASDAQ:CELZ) +52%, Pear Therapeutics (NASDAQ:PEAR) +33%, GBS (NASDAQ:GBS) +30%, PainReform (NASDAQ:PRFX) +15%. Losers: Applied Therapeutics (NASDAQ:APLT) -30%, Nutriband (NTRBW) -24%, AgeX T...
Seekingalpha · 01/03 16:00
65 Biggest Movers From Yesterday
Gainers Society Pass Incorporated (NASDAQ: SOPA) shares climbed 240.2% to close at $11.26 on Monday after the company reported addition to the Russell 2000 Index.
Benzinga · 12/21/2021 10:25
38 Stocks Moving In Monday's Mid-Day Session
Gainers Society Pass Incorporated (NASDAQ: SOPA) shares jumped 120.9% to $7.31 after the company reported addition to the Russell 2000 Index.
Benzinga · 12/20/2021 17:07
NVAX, BPMP and FSM among pre market gainers
Can-Fite BioPharma (NYSE:CANF) +71% liver cancer patient treated with can-Fite’s Namodenoson clears all cancer lesions under open label extension of phase II study. Society Pass Incorporated (NASDAQ:SOPA) +35% on being added to
Seekingalpha · 12/20/2021 13:24
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Benzinga · 12/20/2021 13:08
25 Stocks Moving in Monday's Pre-Market Session
Gainers Society Pass Incorporated (NASDAQ: SOPA) rose 68% to $5.59 in pre-market trading after the company reported addition to the Russell 2000 Index.
Benzinga · 12/20/2021 11:35
GBS Inc. Announces Application For FDA Breakthrough Device Designation To Fast Track Rapid Saliva Glucose Test
GBS Inc. (NASDAQ:GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, today announced that in collaboration with
Benzinga · 12/13/2021 13:02
More
Forecast
No Data
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of GBS. Analyze the recent business situations of GBS Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-1.82%
Pharmaceuticals & Medical Research
-1.11%
Key Executives
Non-Executive Chairman/Independent Director
Stephen Boyages
President/Chief Executive Officer/Director
Harry Simeonidis
Chief Financial Officer
Spiro Sakiris
Independent Director
Lawrence Fisher
Independent Director
Jonathan Hurd
Independent Director
Leon Kempler
Independent Director
George Margelis
Independent Director
Tom Parmakellis
Independent Director
Jonathan Sessler
Independent Director
Christopher Towers
No Data
About GBS
GBS Inc. is a biosensor diagnostic technology company operating across the Asia-Pacific Region (APAC). The Company’s offers various products, including Biosensor Platform Technology, Saliva Glucose Test (SGT) and Saliva Glucose Biosensor (SGB). The Biosensor Platform is an Organic Thin Film Transistor (OTFT) architecture. The basis OTFT structure consists of a source and drain electrode, a semiconducting layer, a gate electrode, an optional separation or dielectric layer, all printed on a substrate material and superimposed by a polyelectrolyte membrane/enzyme layer onto which the analyte is placed. The SGT consists of the SGB, a single use disposable saliva biosensor, and software application on a smart device or a dedicated reader that interfaces the SGB with its digital information system. The SGB interacts with the glucose in the saliva and initiates an electrochemical reaction, producing an electrical signal directly correlated to the amount of glucose present in the saliva.

Webull offers kinds of Gbs Inc stock information, including NASDAQ:GBS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GBS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading GBS stock methods without spending real money on the virtual paper trading platform.